Cresco Labs Balance Sheet Health
Financial Health criteria checks 3/6
Cresco Labs has a total shareholder equity of $428.1M and total debt of $411.8M, which brings its debt-to-equity ratio to 96.2%. Its total assets and total liabilities are $1.4B and $930.4M respectively. Cresco Labs's EBIT is $63.2M making its interest coverage ratio 1. It has cash and short-term investments of $103.4M.
Key information
96.2%
Debt to equity ratio
US$411.83m
Debt
Interest coverage ratio | 1x |
Cash | US$103.43m |
Equity | US$428.07m |
Total liabilities | US$930.40m |
Total assets | US$1.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CRLB.F's short term assets ($278.1M) exceed its short term liabilities ($200.2M).
Long Term Liabilities: CRLB.F's short term assets ($278.1M) do not cover its long term liabilities ($730.2M).
Debt to Equity History and Analysis
Debt Level: CRLB.F's net debt to equity ratio (72%) is considered high.
Reducing Debt: CRLB.F's debt to equity ratio has increased from 0% to 96.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CRLB.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CRLB.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 3.1% per year.